Delfini Lisa has filed 11 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 72000 shares of Trevi Therapeutics, Inc. ($TRVI) on May 31, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | A | Performance Stock Option (right to buy) | 72000 | $0.00 | 110,400.0000 | 101,971,873 | 187.50% | 0.07% |
| March 10, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | A | Performance Stock Option (right to buy) | 38400 | $0.00 | 38,400.0000 | 101,971,873 | 9999.99% | 0.04% |
| Feb. 18, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | A | Stock Option (right to buy) | 225500 | $0.00 | 225,500.0000 | 101,971,873 | 9999.99% | 0.22% |
| Jan. 7, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Common Stock | 1000 | $0.51 | 59,660.0000 | 101,971,873 | 1.70% | 0.00% |
| Jan. 8, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Common Stock | 5000 | $0.51 | 64,660.0000 | 101,971,873 | 8.38% | 0.00% |
| Jan. 7, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 1000 | $0.00 | 47,125.0000 | 101,971,873 | 2.08% | 0.00% |
| Jan. 8, 2025 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 42,125.0000 | 101,971,873 | 10.61% | 0.00% |
| May 22, 2024 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Common Stock | 16043 | $0.51 | 57,629.0000 | 99,033,373 | 38.58% | 0.02% |
| May 22, 2024 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | S | Common Stock | 4350 | $2.64 | 53,279.0000 | 99,033,373 | 7.55% | 0.00% |
| May 22, 2024 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 16043 | $0.00 | 48,125.0000 | 99,033,373 | 25.00% | 0.02% |
| Feb. 15, 2024 | Trevi Therapeutics, Inc. | $TRVI | Delfini Lisa | Chief Financial Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 99,033,373 | 9999.99% | 0.18% |